Skip to main content

Table 3 Pathologic response of high and low Ascore groups in Gulou-Cohort2

From: Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer

Characteristic

No (%)

P value

Ascore-High (N = 20)

Ascore-Low (N = 20)

 

Pathological response

 CR

3 (7.5%)

10 (25%)

 

 PR

9 (22.5%)

1 (2.5%)

 

 SD

3 (7.5%)

7 (17.5%)

 

 PD

5 (12.5%)

2 (5%)

0.004 **

Binary response

 Responder (SD + PD)

5 (12.5%)

18 (45%)

 

 Non-responder (CR + PR)

15 (37.5%)

2 (5%)

 < 0.001 ***

CR response

 CR

3 (7.5%)

10 (25%)

 

 Non-CR

17 (42.5%)

10 (25%)

0.041 *

  1. †CR complete response, PR partial response, SD stable disease, PD progression disease
  2. †,*P < 0.05
  3. **P < 0.01
  4. ***P < 0.001